CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 217 SEK 1.17% Market Closed
Market Cap: 5.2B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Free Cash Flow
kr152.4m
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
13%
Elekta AB (publ)
STO:EKTA B
Free Cash Flow
kr817m
CAGR 3-Years
-22%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Free Cash Flow
kr73m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Free Cash Flow
kr1.6B
CAGR 3-Years
-36%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Free Cash Flow
kr1.7B
CAGR 3-Years
4%
CAGR 5-Years
38%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Free Cash Flow
kr18.7m
CAGR 3-Years
87%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

CellaVision AB
Glance View

Market Cap
5.2B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
265.65 SEK
Undervaluation 18%
Intrinsic Value
Price

See Also

What is CellaVision AB's Free Cash Flow?
Free Cash Flow
152.4m SEK

Based on the financial report for Sep 30, 2024, CellaVision AB's Free Cash Flow amounts to 152.4m SEK.

What is CellaVision AB's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
13%

Over the last year, the Free Cash Flow growth was 153%. The average annual Free Cash Flow growth rates for CellaVision AB have been 17% over the past three years , 10% over the past five years , and 13% over the past ten years .

Back to Top